Eli Lilly to Acquire Dice Therapeutics for $2.4 Billion in A

Dice is a biopharmaceutical company that uses a proprietary technology platform to develop new oral therapeutic drugs for autoimmune diseases.

Related Keywords

Eli Lilly , Patrik Jonsson , Dice Therapeutics , San Francisco Based ,